The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Could chest wall rigidity be a factor in rapid death from illicit fentanyl abuse?
Abstract
BACKGROUND: There has been a significant spike in fentanyl-related deaths from illicit fentanyl supplied via the heroin trade. Past fentanyl access was primarily oral or dermal via prescription fentanyl patch diversion. One factor potentially driving this increase in fatalities is the change in route of administration. Rapid intravenous (IV) fentanyl can produce chest wall rigidity. We evaluated post-mortem fentanyl and norfentanyl concentrations in a recent surge of lethal fentanyl intoxications. METHODS: Fentanyl related deaths from the Franklin County coroner's office from January to September 2015 were identified. Presumptive positive fentanyl results were confirmed by quantitative analysis using liquid chromatography tandem mass spectrometry (LC/MS/MS) and were able to quantify fentanyl, norfentanyl, alfentanyl, and sufentanyl. RESULTS: 48 fentanyl deaths were identified. Mean fentanyl concentrations were 12.5 ng/ml, (range 0.5 ng/ml to >40 ng/ml). Mean norfentanyl concentrations were 1.9 ng/ml (range none detected to 8.3 ng/ml). No appreciable concentrations of norfentanyl could be detected in 20 of 48 cases (42%) and were less than 1 ng/ml in 25 cases (52%). Elevated fentanyl concentrations did not correlate with rises in norfentanyl levels. In several cases fentanyl concentrations were strikingly high (22 ng/ml and 20 ng/ml) with no norfentanyl detected. DISCUSSION: The lack of any measurable norfentanyl in half of our cases suggests a very rapid death, consistent with acute chest rigidity. An alternate explanation could be a dose-related rapid onset of respiratory arrest. Deaths occurred with low levels of fentanyl in the therapeutic range (1-2 ng/ml) in apparent non-naïve opiate abusers. Acute chest wall rigidity is a well-recognized complication in the medical community but unknown within the drug abuse community. The average abuser of illicit opioids may be unaware of the increasing fentanyl content of their illicit opioid purchase. CONCLUSION: In summary we believe sudden onset chest wall rigidity may be a significant and previously unreported factor leading to an increased mortality, from illicit IV fentanyl use. Fentanyl and norfentanyl ratios and concentrations suggest a more rapid onset of death given the finding of fentanyl without norfentanyl in many of the fatalities. Chest wall rigidity may help explain the cause of death in these instances, in contrast to the typical opioid-related overdose deaths. Intravenous heroin users should be educated regarding this potentially fatal complication given the increasingly common substitution and combination with heroin of fentanyl.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lack of metabolism of fentanyl to norfentanyl might be the result of rapid death after fentanyl use (10).”
From Multiple Fentanyl Overdoses — New Haven, Connecticut, June 23, 2016 (2017) · cites this paper as [10]
Citations
Cites
Opioids and the control of respiration
Pattinson, K. T. S. (2008) · British Journal of Anaesthesia · doi:10.1093/bja/aen094 · Cited by 794
McClain, D. A., & Hug, C. C. (1980) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1980.138 · Cited by 520
Heroin-related deaths in New South Wales, Australia, 1992–1996
Darke, S. G., Ross, J. E., ZADOR, D. A., & Sunjic, S. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00147-7 · Cited by 216
Fentanyl Use, Misuse, and Abuse: A Summary of 23 Postmortem Cases
Kuhlman, J. J., McCaulley, R. A., Valouch, T. J., & Behonick, G. S. (2003) · Journal of Analytical Toxicology · doi:10.1093/jat/27.7.499 · Cited by 136
Disposition of Heroin and Its Metabolites in Heroin-Related Deaths
Goldberger, B. A., Cone, E. J., Grant, T. M., Caplan, Y. H., LEVINE, B. S., & Smialek, J. E. (1994) · Journal of Analytical Toxicology · doi:10.1093/jat/18.1.22 · Cited by 132
Drug concentrations in post‐mortem femoral blood compared with therapeutic concentrations in plasma
Launiainen, T., & Ojanperä, I. A. (2013) · Drug Testing and Analysis · doi:10.1002/dta.1507 · Cited by 121
Hemodynamic Changes during Fentanyl—Oxygen Anesthesia for Aortocoronary Bypass Operation
Waller, J. L., Hug, C. C., Nagle, D., & Craver, J. M. (1981) · Anesthesiology · doi:10.1097/00000542-198109000-00005 · Cited by 115
Fentanyl-Induced Chest Wall Rigidity
Çoruh, B., Tonelli, M. R., & Park, D. R. (2013) · CHEST Journal · doi:10.1378/chest.12-2131 · Cited by 114
Streisand, J. B., Bailey, P. L., Maire, L. L., Ashburn, M. A., Tarver, S. D., Varvel, J. R., & Stanley, T. H. (1993) · Anesthesiology · doi:10.1097/00000542-199304000-00003 · Cited by 101
Morphine Concentrations and Survival Periods in Acute Heroin Fatalities
Garriott, J. C., & Sturner, W. Q. (1973) · New England Journal of Medicine · doi:10.1056/nejm197312132892404 · Cited by 87
Research works printed but not linked: 7
- Mercado-Crespo MC, 2014, MMWR, 63, 531
- Drug enforcement administration, US department of justice, 2008, Fed Regist, 73, 43355
- Ackerman WE, 1990, Anesth Prog, 37, 46
- Tanus-Santos JE., 1998, BMJ, 317, 1386
- Dimitriou V, 2014, Middle East J Anesthesiol, 22, 619
- Vaughn RL, 1981, Anesth Prog, 28, 50
- Lee TY, 1995, Neurosci Lett, 199:195
Cited by
Sorted by citations
Items 101–126 of 126
Intravenous Fentanyl and Potential Mortality
Ruan, X., Wu, H., & Sehgal, N. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.8753 · Cited by 1
Opioid Abuse and Opioid Epidemic
Dasgupta, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820075-9.00003-x · Cited by 1
Jones, J. D., Luba, R. R., Mumtaz, M., & Castillo, F. (2023) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780197618431.013.30 · Cited by 1
Basic Substance Characteristics and Neuropathological Findings in Drug Abusers
Büttner, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-60531-5_4 · Cited by 1
Grundlegende Substanzmerkmale und neuropathologische Befunde bei Drogenkonsumenten
Büttner, A. (2022) · Springer eBooks · doi:10.1007/978-3-031-13619-1_4 · Cited by 1
Spiller, H. A., Burns, G., & Casavant, M. J. (2016) · Clinical Toxicology · doi:10.1080/15563650.2016.1199031 · Cited by 1
Self-citationCommentary: New Complications Make Treatment of “Opioid” Overdose Challenging
Peppin, J. F., Pergolizzi, J. V., Dahan, A., & Raffa, R. B. (2020) · Pharmacology & Pharmacy · doi:10.4236/pp.2020.1112029 · Cited by 1
Naloxone administration—no balance without titration
Skulberg, A. K., Tylleskär, I., & Dale, O. (2022) · Addiction · doi:10.1111/add.15947 · Cited by 1
DOENÇAS CRÔNICAS NÃO TRANSMISSÍVEIS
LIMA, L. R., & Soares, L. O. L. (2024) · doi:10.56161/sci.ed.20240220033 · Cited by 1
The fentanyls: pharmacological and clinical aspects relevant to Australia
Greene, S. L., Scamvougeras, A., Norman, A. F., Bonomo, Y. A., & Castle, D. J. (2020) · Australasian Psychiatry · doi:10.1177/1039856220917317
The Biological Activity of Designer Drugs from the Group of Synthetic Opioids
Головко, А. И., Ivnitsky, J. J., Ivanov, M. B., Rejniuk, V. L., & Kozlov, V. K. (2021) · Biology Bulletin Reviews · doi:10.1134/s2079086421020031
Lappas, N. T., & Lappas, C. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819286-3.00025-7
(2016) · Reactions Weekly · doi:10.1007/s40278-016-19839-5
Κ-Opioid Agonist Potentiates Reversal of Fentanyl Overdose by NaloxonePreprint
CERNEA, M. S., Nikonov, G., Ataiants, J., Ştefănuţ, C., Abernethy, J., & Voronkov, M. V. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4660812
Análisis toxicológico y mortalidad asociada al Carfentanilo
Vega, G. A. C., Angarita, J. E. V., Hernández, M. J. A., & Macías, J. D. R. (2023) · Revista Biociencias · doi:10.18041/2390-0512/biociencias.1.10636
Nunes, J. M. P. F. (2024) · doi:10.56161/sci.ed.20240220033c1
Garland, H., & Ladds, G. (2025) · British Journal of Anaesthesia · doi:10.1016/j.bja.2025.04.044
Fentanyl: A threat to Brazilian society or an opioid drug of great importance in pain management?
Kuhn, G. P., Bigal, A. L., & Nappo, S. A. (2025) · Saúde e Sociedade · doi:10.1590/s0104-12902025240397en
Rivera, A., Schutzer, W. E., Sonneborn, A., Shotwell, S., Janowsky, A. J., Abbas, A. I., & Torralva, R. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.07.687263
Investigation of opioid antagonist activity of novel fluorinated derivative of diprenorphine
Chalysheva, A. E., Dravolina, O. A., Kurskaya, O. V., Sandulenko, I. V., & Belozertseva, I. V. (2025) · Психофармакология и биологическая наркология · doi:10.17816/phbn696673
Miller, C. O. G. (2025) · Springer eBooks · doi:10.1007/978-3-032-13315-1_3
Kent, J. T., Culbreth, R. E., Lebin, J. A., Burkhart, K., Hendrickson, R. G., Dezman, Z. D. W., Aldy, K., Brent, J. A., Falise, A. M., Campleman, S. L., et al. (2026) · Journal of Medical Toxicology · doi:10.1007/s13181-026-01132-w
Dermorphin blocks apneic response to intravenous bolus injection of fentanyl
ZHUANG, J., Gao, X., Shi, S., & Xu, F. (2026) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2026.117785
Beyond the patch: outpatient management of fentanyl misuse with levomethadone
Marzolla, M., Consoli, A., Beccaria, F., Menga, A., Stefania, S., & Ruggero, G. (2026) · Journal of Substance Use · doi:10.1080/14659891.2026.2679104
da Silva, M. L. O., Barbosa, J., & Dinis‐Oliveira, R. J. (2026) · Forensic Science Medicine and Pathology · doi:10.1007/s12024-026-01331-5
Use of analgesics in older individuals with special emphasis on organ failures: pitfalls and caveats
Ucar, A., Ünaldı, M., Kaytuoğlu, N., ERDEM, B., Özkaya, B., Bozkurt, S., Vargun, P., Şahin, Ş., Girgin, M. C., Çiftçi, T., et al. (2026) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-026-00716-w
Metadata
- Authors
- Burns, G., DeRienz, R. T., Baker, D. D., Casavant, M., & Spiller, H. A.
- Affiliations
- The Ohio State University (US)
- Office of the Franklin County Coroner, Division of Forensic Toxicology, Columbus, OH, USA;
- Corresponding author
- Spiller, Henry A.
- Venue
- Clinical Toxicology
- Publisher
- Informa UK Limited
- Published
- 2016-03-21
- Volume
- 54
- Issue
- 5
- Pages
- 420-423
- ISSN
- 0009-9309 (ISSN-L)
- 1556-3650
- 1556-9519
- OpenAlex
- W2304006660
- Cited by
- 126
- References
- 27
- Citations by year
- 2026: 9 · 2025: 16 · 2024: 17 · 2023: 8 · 2022: 7 · 2021: 15 · 2020: 12 · 2019: 14 · 2018: 8 · 2017: 13 · 2016: 7
- FWCI
- 11.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
- Keywords
- chest wall rigidity, illicit fentanyl, norfentanyl, opioid overdose, rapid death, postmortem toxicology, respiratory arrest, heroin trade, sufentanil, route of administration, Franklin County, Ohio
- MeSH terms
- Administration, Cutaneous, Administration, Oral, Adult, Analgesics, Opioid, Autopsy, Cause of Death, Female, Fentanyl, Humans, Male, Middle Aged, Narcotics, Thoracic Wall, Forensic Toxicology, Tandem Mass Spectrometry, Young Adult, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review